Get started
Eton Pharmaceuticals, Inc.Eton Pharmaceuticals, Inc.Eton Pharmaceuticals, Inc.

Eton Pharmaceuticals, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

ETON chart


Full chart

ETON upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪226.84 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.26 USD
Net income (FY)
‪−936.00 K‬ USD
Revenue (FY)
‪31.64 M‬ USD
Shares float
‪24.46 M‬
Beta (1Y)
1.24

Employees


Employees (FY)
30
Change (1Y)
+2 +7.14%
Revenue / Employee (1Y)
‪1.05 M‬ USD
Net income / Employee (1Y)
‪−31.20 K‬ USD

About Eton Pharmaceuticals, Inc.


Sector
Health Technology
CEO
Sean E. Brynjelsen
Headquarters
Deer Park
Website
etonpharma.com
Founded
2017
FIGI
BBG00H0KCMV1
Eton Pharmaceuticals, Inc. engages in the development, acquisition, and commercialization of prescription drug products. Its products include Biorphen, Alaway Preservative Free, zonisamide oral suspension, topiramate oral suspension, lamotrigine for oral suspension, cysteine injection, and ephedrine ready-to-use injection. The company was founded in April 2017 and is headquartered in Deer Park, IL.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

ETON news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ETON is 8.78 USD — it has increased by 1.27% in the past 24 hours. Watch Eton Pharmaceuticals, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Eton Pharmaceuticals, Inc. stocks are traded under the ticker ETON.
ETON stock has risen by 2.93% compared to the previous week, the month change is a 17.07% rise, over the last year Eton Pharmaceuticals, Inc. has showed a 99.55% increase.
We've gathered analysts' opinions on Eton Pharmaceuticals, Inc. future price: according to them, ETON price has a max estimate of 15.00 USD and a min estimate of 11.00 USD. Watch ETON chart and read a more detailed Eton Pharmaceuticals, Inc. stock forecast: see what analysts think of Eton Pharmaceuticals, Inc. and suggest that you do with its stocks.
ETON reached its all-time high on Feb 9, 2021 with the price of 10.30 USD, and its all-time low was 1.95 USD and was reached on Sep 23, 2022. View more price dynamics on ETON chart.
See other stocks reaching their highest and lowest prices.
ETON stock is 4.09% volatile and has beta coefficient of 1.24. Track Eton Pharmaceuticals, Inc. stock price on the chart and check out the list of the most volatile stocks — is Eton Pharmaceuticals, Inc. there?
Today Eton Pharmaceuticals, Inc. has the market capitalization of ‪226.84 M‬, it has increased by 6.23% over the last week.
Yes, you can track Eton Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
Eton Pharmaceuticals, Inc. is going to release the next earnings report on Nov 12, 2024. Keep track of upcoming events with our Earnings Calendar.
ETON earnings for the last quarter are −0.12 USD per share, whereas the estimation was −0.07 USD resulting in a −71.43% surprise. The estimated earnings for the next quarter are −0.01 USD per share. See more details about Eton Pharmaceuticals, Inc. earnings.
Eton Pharmaceuticals, Inc. revenue for the last quarter amounts to ‪9.07 M‬ USD, despite the estimated figure of ‪8.80 M‬ USD. In the next quarter, revenue is expected to reach ‪9.70 M‬ USD.
ETON net income for the last quarter is ‪−3.04 M‬ USD, while the quarter before that showed ‪−811.00 K‬ USD of net income which accounts for −274.97% change. Track more Eton Pharmaceuticals, Inc. financial stats to get the full picture.
No, ETON doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 10, 2024, the company has 30.00 employees. See our rating of the largest employees — is Eton Pharmaceuticals, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Eton Pharmaceuticals, Inc. EBITDA is ‪−5.27 M‬ USD, and current EBITDA margin is −0.92%. See more stats in Eton Pharmaceuticals, Inc. financial statements.
Like other stocks, ETON shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Eton Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Eton Pharmaceuticals, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Eton Pharmaceuticals, Inc. stock shows the strong buy signal. See more of Eton Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.